These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25483697)

  • 1. Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta.
    Tian G; Qi Z; Qiu Y; Wu X; Zhang Q; Yang X; Xin Y; He J; Bi Y; Wang Q; Zhou J; Fan Y; Zhou Y; Jiang Y; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(12):3552-60. PubMed ID: 25483697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
    Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological observation of immunized rhesus macaques with plague vaccines after subcutaneous infection of Yersinia pestis.
    Tian G; Qiu Y; Qi Z; Wu X; Zhang Q; Bi Y; Yang Y; Li Y; Yang X; Xin Y; Li C; Cui B; Wang Z; Wang H; Yang R; Wang X
    PLoS One; 2011 Apr; 6(4):e19260. PubMed ID: 21559437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta.
    Qiu Y; Liu Y; Qi Z; Wang W; Kou Z; Zhang Q; Liu G; Liu T; Yang Y; Yang X; Xin Y; Li C; Cui B; Huang S; Liu H; Zeng L; Wang Z; Yang R; Wang H; Wang X
    Scand J Immunol; 2010 Nov; 72(5):425-33. PubMed ID: 21039737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.
    Oyston PC; Mellado-Sanchez G; Pasetti MF; Nataro JP; Titball RW; Atkins HS
    Microb Pathog; 2010 May; 48(5):191-5. PubMed ID: 20096773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
    Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
    Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Live-Attenuated Vaccine Strain of
    Feng J; Deng Y; Fu M; Hu X; Luo W; Lu Z; Dai L; Yang H; Zhao X; Du Z; Wen B; Jiang L; Zhou D; Jiao J; Xiong X
    Front Cell Infect Microbiol; 2020; 10():473. PubMed ID: 33014895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model.
    Zhang X; Qi Z; Du Z; Bi Y; Zhang Q; Tan Y; Yang H; Xin Y; Yang R; Wang X
    Vaccine; 2013 May; 31(22):2539-42. PubMed ID: 23588087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Live Plague Vaccine Candidates.
    Feodorova VA; Sayapina LV; Motin VL
    Methods Mol Biol; 2016; 1403():487-98. PubMed ID: 27076149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.
    Welkos S; Pitt ML; Martinez M; Friedlander A; Vogel P; Tammariello R
    Vaccine; 2002 May; 20(17-18):2206-14. PubMed ID: 12009274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis.
    Van Andel R; Sherwood R; Gennings C; Lyons CR; Hutt J; Gigliotti A; Barr E
    Comp Med; 2008 Feb; 58(1):68-75. PubMed ID: 19793459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice.
    Anisimov AP; Shaikhutdinova RZ; Pan'kina LN; Feodorova VA; Savostina EP; Bystrova OV; Lindner B; Mokrievich AN; Bakhteeva IV; Titareva GM; Dentovskaya SV; Kocharova NA; Senchenkova SN; Holst O; Devdariani ZL; Popov YA; Pier GB; Knirel YA
    J Med Microbiol; 2007 Apr; 56(Pt 4):443-453. PubMed ID: 17374882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity in plague: protection of the vervet (Cercopithecus aethips) against pneumonic plague by the oral administration of live attenuated Yersinia pestis.
    Chen TH; Elberg SS; Eisler DM
    J Infect Dis; 1977 Feb; 135(2):289-93. PubMed ID: 402428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infectious-toxic model of plague in mice].
    Ryzhko IV; Mishan'kin BN; Tsuraeva RI; Shcherbaniuk AI; Anisimov BI
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):46-50. PubMed ID: 19621819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioluminescent tracking of colonization and clearance dynamics of plasmid-deficient Yersinia pestis strains in a mouse model of septicemic plague.
    Zhou J; Bi Y; Xu X; Qiu Y; Wang Q; Feng N; Cui Y; Yan Y; Zhou L; Tan Y; Yang H; Du Z; Han Y; Song Y; Zhang P; Zhou D; Cheng Y; Zhou Y; Yang R; Wang X
    Microbes Infect; 2014 Mar; 16(3):214-24. PubMed ID: 24333143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
    Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
    Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative genetic characteristic of vaccine strain of Yersinia pestis EV and its putative "virulent derivatives"].
    Kutyrev VV; Eroshenko GA; Kukleva LM; Shavina NIu; Vinogradova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):50-6. PubMed ID: 19621820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.